CDSCO monthly lab alert
CDSCO NSQ alert, May 2025: 188 drug batches flagged
By Blacklisted editorial team· Published 20 Jun 2025· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its May 2025 alert, the Central Drugs Standard Control Organisation listed 188 drug batches that failed quality tests, 58 at central laboratories and 130 at state drug-testing laboratories, from 153 manufacturers across 143 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Pantoprazole for Injection BP 40 mg, Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500), White Powder Paracetamol IP.
188
Batches flagged
58 / 130
Central / state labs
Assay
Top reason
153
Manufacturers
Batches per month, last 12 alerts
Jun 2024May 2025 · 188
Full list of NSQ batches, May 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Zinc Sulphate Tablets I.P. 20 mg (TONZEE 20) | ZS-2404Mfg 2024-05 · Exp 2026-04 | Torino Laboratories Pvt. LtdMadhya Pradesh | The Sample does not conform to Standard Quality in respect of the test for DisintegrationDisintegration | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Zinc Sulphate Dispersible Tablets IP 20 mg | LMT240804Mfg 2024-07 · Exp 2026-06 | Life Max Cancer Laboratories | Uniformity of Dispersion & DisintegrationDisintegration | RDTL, GuwahatiCDSCO lab |
| Zaflox-OZ Tablet | TLT-6938Mfg 2024-02 · Exp 2026-01 | Taksa Lifescience E-47Chandigarh | 1.The sample fails in the Dissolution Test of Ofloxacin IP & Ornidazole IP 2.The sample does not conform to the Assay content of Ofloxacin IP 3.The sample is also found Misbranded as Ofloxacin and Ornidazole Tablets are not been shown official as per I.P 2022Assay | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| White Powder Paracetamol IP | PAR040325Mfg 2025-03 · Exp 2030-02 | Samarth Pharmaceuticals Office No. 201 GIDC Shopping Centre Morarji Circle GIDC Vapi-396195 | Identification Test Found To be Negative. Assay of Paracetamol IP-NILAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| White Powder Paracetamol IP | PAR050325Mfg 2025-03 · Exp 2030-02 | Samarth Pharmaceuticals Office No. 201 GIDC Shopping Centre Morarji Circle GIDC Vapi-396195 | Identification Test Found To be Negative. Assay of Paracetamol IP-NILAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| Vitamin B-Complex with Vitamin C and Biotin Capsules (Vitabon ) | C-3465Mfg 2024-11 · Exp 2026-10 | Jackson Laboratories Pvt. LtdPunjab | Assay/content of Calcium PantothenateAssay | CDL, KolkataCDSCO lab |
| Vitamin B Complex Injection 30 ml (WA-PLEX ) | 111Mfg 2024-12 · Exp 2026-05 | Weismanna Health Care Pvt. LtdAndhra Pradesh | Description and Particulate matterDescription | CDL, KolkataCDSCO lab |
| Ursodeoxycholic acid Tablets IP 300 mg | UDS-501Mfg 2024-08 · Exp 2026-07 | Healers Lab Unit II Plot NO. 33Himachal Pradesh | The sample does not confirm to claim as per IP 2022 in respect to the Dissolution of Ursodiol ( Ursodeoxycholic Acid)Dissolution | DTL Baddi Distt. SolanState lab |
| Trypsin, Bromelain, Rutoside, Trihydrate & Diclofenac Tablets (RUMIHEAL-D) | SRTF240703BMfg 2024-06 · Exp ? | Systole Remedies Pvt. Ltd.. Vill-OgliHimachal Pradesh | Test for DisintegrationDisintegration | DTL Baddi Distt Solan HPState lab |
| Trenbolone Enanthate Injection 200mg/ml (FINAREX 200) | TST2301Mfg ? · Exp 2027-04 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Trenbolone Acetate Injection 100mg/ml... (FINEXAL 100) | TST2301Mfg ? · Exp 2027-04 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Tranexamic Acid Tablets IP (Trenaxa 500 ) | 18242021AMfg 2024-08 · Exp 2027-07 | Macleods Pharmaceuticals LtdSikkim | Spurious Identification and Assay of Tranexamic AcidAssay | CDL, KolkataCDSCO lab |
| Testosterone Propionate 100mg/ml (P-JECT) | INLDAN1801Mfg 2024-02 · Exp 2028-01 | Novector Labs | Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Telmisartan Tablets IP 40mg (Telma 40) | K18230707Mfg 2024-06 · Exp 2027-05 | Under Investigation | Identification and Assay of TelmisartanAssay | CDL, KolkataState lab |
| Telmisartan Tablets IP 40mg | 251TTF025Mfg 2024-12 · Exp 2027-11 | Swiss Garnier Life SciencesHimachal Pradesh | DissolutionDissolution | RDTL, GuwahatiCDSCO lab |
| Telmisartan Tablets IP 40 mg | 251TTF036Mfg 2024-12 · Exp 2026-11 | Swiss Garnier Life SciencesHimachal Pradesh | DissolutionDissolution | RDTL, GuwahatiCDSCO lab |
| Telmisartan Tablets I.P. 40mg (Telma 40) | 5240226Mfg 2024-02 · Exp 2027-01 | Under Investigation | DissolutionDissolution | CDL, KolkataState lab |
| Telmisartan Tablets I.P. 20 mg (TELSAT ? 20) | ST2T2302Mfg 2024-03 · Exp 2026-02 | Goodman Pharmaceuticals | The Sample does not conform to standard in respect of the test for Dissolution performedDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Telmisartan & Amlodipine TabletsIP (Lanztel-AM) | RHT24-402Mfg 2024-07 · Exp 2026-06 | Revantis HealthcareHimachal Pradesh | Does not comply with respect to test for AssayAssay | State lab , PuducherryState lab |
| Tamsulosin Hydrochloride & Dutasteride tab (Urimax-D | 4GH0097Mfg 2023-12 · Exp 2025-11 | Cipla LtdGoa | Negative for the presence of Tamsulosin Hydrochloride & DutasterideOther | State Drug Control & Research Lab, West BengalState lab |
| Super Bulk-Mix Rx Only (Super Bulk-Mix Rx) | CQ20215MIOSMfg 2024-02 · Exp 2027-01 | Not applicable | Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Sulphamethoxazole &Trimethoprim Injection I.P. | EL-240608Mfg 2024-06 · Exp 2026-05 | Ethicare LaboratoriesJammu & Kashmir | The sample does not conform to the IP (Vet.) with respect to Particulate Matter, Description as it show physical in stability in the form of white crystalline particles and Assay of TrimethoprimAssay | DTL,Jaipur(State Lab)State lab |
| Sulcralfate& Oxetacaine Suspension( Piracid-O Suspension) | R05GL2423AMfg 2024-05 · Exp 2026-04 | Rednex Pharmaceuticals Pvt. LtdKerala | Assay for Oxetacaine OnlyAssay | KarnatakaState lab |
| Sucralfate Oral Suspension (AXID 200) | 624-470Mfg 2024-06 · Exp 2026-05 | Zee Laboratories Ltd | The sample does not conform to claim standards with respect to descriptionDescription | CDTL- ChennaiCDSCO lab |
| Sterile Diluent For Reconstitution of ND, IB, IBD and Combination Vaccines for Poultry (Veterinary) Multi | GSCEV03Mfg 2023-11 · Exp 2025-10 | Safe Parenterals Pvt.LtdAndhra Pradesh | Description & Particulate MatterDescription | KarnatakaState lab |
| Stanozolol Injection 100mg/ml (VENAJECT) | TST2301Mfg ? · Exp 2027-04 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Spnflox-OZ Tablets (Ofloxacin &OrnidazoleTablets IP) | DT240523BMfg 2024-05 · Exp 2026-04 | Indo Rama Health Care Pvt.Ltd | Description of TabletsDescription | KarnatakaState lab |
| Sodium Valporate IP Powder | SV/02/01/25Mfg 2025-01 · Exp 2029-12 | Mirambika Pigment | Loss on drying: Does not comply with IP, Assay of Sodium Valporate IP: More than Prescribed LimitAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| Sodium Chloride InjectionIP0.9% w/v (NS) | UA404B026Mfg 2025-01 · Exp 2027-12 | Puniska lnjectables Pvt.LtdGoa | Test for SterilitySterility | KarnatakaState lab |
| Sodium Chloride Injection U.S.P.(3% w/v ) (Hypertonic 3NS 100 ml) | G250146001Mfg 2025-01 · Exp 2027-12 | Vision Parental Pvt. Ltd | Particulate MatterParticulate matter | CDL, KolkataCDSCO lab |
| Sodium Chloride Injection IP 0.9% w/v (NS) | TL304F003Mfg 2024-11 · Exp 2027-10 | Puniska lnjectables Pvt.LtdGoa | Test for SterilitySterility | KarnatakaState lab |
| Sodium Chloride Injection I.P. (0.9% w/v).. (NS) | 01BF2354Mfg 2024-03 · Exp 2027-02 | Paschim Banga Pharmaceutical (A Unit Of FARISTA VANIJYA Pvt. Ltd.) | Sterillity & DescriptionDescription | RDTL, GuwahatiCDSCO lab |
| Sitagliptin & Metformin Tablets 50 mg + 1000 mg (Sitajack-M ) | T-2916Mfg 2024-09 · Exp 2026-08 | Jackson Laboratories Pvt. LtdPunjab | Assay of SitagliptinAssay | CDL, KolkataCDSCO lab |
| Sildenafil citrate oral jelly 5 gm (King of jelly) | 25005Mfg 2025-02 · Exp 2028-01 | Banson Pharmaceuticals Pvt.Ltd | Description and Assay of Sildenafil CitrateAssay | RDTL, ChandigarhCDSCO lab |
| SPORLAC Tablets (Tablets of Probiotics) | MS024004Mfg 2024-04 · Exp 2026-05 | J.B. Chemicals & Pharmaceuticals LtdUttarakhand | Identification of Bacillus clausiiIdentification | CDTL-MumbaiCDSCO lab |
| Robiflam-SP | UTGRFB401Mfg 2024-05 · Exp 2026-04 | Khandelwal Laboratories Pvt LtdUttarakhand | The sample fails in the test for Description of tabletsDescription | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Ranitidine Injection IP-2ML | HLI352CMfg 2024-03 · Exp 2026-02 | Himalaya Meditek Pvt LtdUttarakhand | Sample does not conform to requirement for AssayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Ranitidine Hydrochloride Tablets IP 150mg (Zeptiloc-150 tablets) | ZCI24003Mfg 2024-04 · Exp 2026-03 | Danish Healthcare (P) Ltd. 76/27-28 | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Rabeprazole Sodium Injection IP 20 mg/vial | MD23H27Mfg 2023-08 · Exp 2025-07 | Martin & Brown Bio SciencesHimachal Pradesh | pH, Clarity of Solution, Particulate matter, Uniformity of Weight, Assay of Rabeprazole Sodium and Description.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Gastro- resistant & Domperidone (SR) Capsules (Rebtil-DSR) | LV23LC-017Mfg 2023-11 · Exp 2025-10 | L.V. Life SciencesHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL,Bikaner (State Lab)State lab |
| Rabeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules (Kylid-RD) | NHD24207CMfg 2024-05 · Exp 2026-04 | Nest Healthcare Pvt LtdGujarat | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL, Jaipur (State Lab)State lab |
| Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Releases) Capsules (Rzol-D) | SSC23187Mfg 2024-01 · Exp 2025-12 | Shri Sai Bala Ji Pharmatech Pvt.LtdHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Rabeprazole SodiumAssay | DTL,Bikaner (State Lab)State lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules (Dorsai) | DYC-24007Mfg 2024-04 · Exp 2026-03 | DYCOTT HealthcareHimachal Pradesh | Dissolution of Rabeprazole Sodium (acid stage), Dissolution of Rabeprazole Sodium (buffer stage) and Assay of Rabeprazole SodiumAssay | CDL, KolkataCDSCO lab |
| Povidone Iodine Gargle 2% (ZEVODINE) | 623-864Mfg 2023-11 · Exp 2025-10 | Zee Laboratories LtdHimachal Pradesh | Test For Assay (Content) of Povidone-Iodine Equivalent To Available-IodineAssay | Government of NCT of DelhiState lab |
| Pomol-650 (Paracetamol Tablets I.P. 650mg) | 24020111Mfg 2024-02 · Exp 2027-01 | Mls.Aban PharmaceuticalsKerala | Test for Dissolution of Tablets and content of Paracetamol in the AssayAssay | KarnatakaState lab |
| Phenytoin Sodium Injection USP-2ml | 45PSA138Mfg 2024-05 · Exp 2026-04 | SPM Drugs (P) Ltd | Sample does not conform to the requirement for assayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Park 650 | AT24/391Mfg 2024-08 · Exp 2026-07 | Accuwell Medics Pvt Ltd Survey No 414Gujarat | The sample fails in the test for Uniformity of Weight of Tablets & Assay content of ParacetamolAssay | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Paracetamol Tablets IP 650mg | PCT24034Mfg 2024-02 · Exp 2026-01 | Vivek Pharmachem (India) LtdRajasthan | The sample has been declared as not of Standard Quality as it does not conform to IP standards with respect to Test for Dissolution and DescriptionDissolution | �KarnatakaState lab |
| Paracetamol Tablets I.P 500mg(Fevimed) | 451AA05Mfg 2023-12 · Exp 2025-11 | Sarv PharmaceuticalsUttarakhand | The sample does not comply for Description as, the tablets shows uneven light Brown Coloured Spots on the Surface of almost all the Tablets.Description | N.S. Bhalerao, Hingoli , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Paracetamol Tablet I.P 500 mg | KA1334Mfg 2023-12 · Exp 2026-11 | Karnataka Antibiotics & Pharmaceuticals LimitedKarnataka | DescriptionDescription | CDTL- IndoreCDSCO lab |
| Paracetamol 250 mg & Mefenamic Acid 100 mg Suspension, 60 ml (Pacimol MF 250 Suspension) | INC014022RMfg 2024-04 · Exp 2026-03 | Ipca Laboratories Ltd | Assay of Paracetamol and Mefenamic AcidAssay | CDTL-MumbaiCDSCO lab |
| Pantoprazole for Injection BP 40 mg | AA013026Mfg 2023-06 · Exp 2025-05 | ANG Lifesciences India LtdHimachal Pradesh | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab |
| Pantoprazole for Injection BP 40 mg | AA013043Mfg 2023-08 · Exp 2025-07 | ANG Lifesciences India LtdHimachal Pradesh | Clarity and colour of solutionDescription | CDL, KolkataCDSCO lab |
| Pantoprazole for Injection BP 40 mg | AA013047Mfg 2023-09 · Exp 2025-08 | ANG Lifesciences India Ltd. Village KishanpuraHimachal Pradesh | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab |
| Pantoprazole Tablets IP 40 mg | 92Mfg 2024-07 · Exp 2026-06 | Hindustan Antibiotics LtdMaharashtra | Dissolution and DescriptionDissolution | CDL, KolkataCDSCO lab |
| Pantoprazole Gastro-Resistant Tablets IP 40 mg, | 431Mfg 2024-11 · Exp 2026-04 | Stride Organics Pvt LimitedTelangana | The drug failed to indicate the common name of the color contained in the drug on the label of the product, as required by Rule 127(2) of the Drugs Rules, 1945. It was mentioned on the label as Approved Colours UsedLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Pantoprazole Gastro resistant &Domperidone prolonged release Capsules IP | PZD242206Mfg 2025-01 · Exp 2026-12 | Paradox PharmaceuticalsHimachal Pradesh | Identification and Assay of Pantoprazole Sodium calculated as Pantoprazole and Domperidone and the Dissolution of Pantoprazole Sodium calculated as Pantoprazle.Assay | RDTL, ChandigarhCDSCO lab |
| Pantoprazole Gastro-resistant & Domperidone Prolonged Release Capsuels IP (Pantocoat- DAR) | C112403Mfg 2024-11 · Exp 2026-10 | Mls.Swefn Pharmaceuticals Pvt.LtdGujarat | Description of TabletsDescription | KarnatakaState lab |
| Ondansetron Injection IP 2 mg/ml | ONA12515Mfg 2025-01 · Exp 2026-12 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | Particulate matterParticulate matter | CDL, KolkataCDSCO lab |
| Ondansertron Orally Disintegrating Tablets IP 4 mg (ONVIN-4 MD TABLETS ) | RV24012Mfg 2024-05 · Exp 2026-04 | Rivpra Formulation Pvt. LtdUttarakhand | Related SubstancesRelated substances | CDL, KolkataCDSCO lab |
| Om Shanthi Gold Class KUMKUM, | BL0lMfg 2024-12 · Exp 2025-11 | N. Rangarao & Sons Pvt.Ltd | Test for Fineness residue onlyOther | KarnatakaState lab |
| Olanzapine Tablets I.P.5mg. (Olanzapine Tablets IP 5mg) | N2503121Mfg 2025-03 · Exp 2028-02 | Talent HealthcareUttarakhand | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Olanzapine Tablet I.P. (Etimok) | ATD-B24020Mfg 2024-02 · Exp 2026-01 | Alzan Pharmaceuticals Pvt | Uniformity of contentUniformity of weight/content | State Drugs Laboratory, PunjabState lab |
| Ofloxacin and Ornidazole Tablets IP 200 mg+500mg | DL-136Mfg 2024-12 · Exp 2026-11 | DUTCH FormulationsHimachal Pradesh | Uniformity of weight, Dissolution of Ornidazole, Dissolution of Ofloxacin and Assay of Ofloxacin and OrnidazoleAssay | RDTL, ChandigarhCDSCO lab |
| Ofloxacin Tablets IP 200 mg | DL-55Mfg 2024-10 · Exp 2026-09 | DUTCH FormulationsHimachal Pradesh | Dissolution and Assay of OfloxacinAssay | RDTL, ChandigarhCDSCO lab |
| Norfloxacin Tablets I.P.400mg, | 4Mfg 2025-02 · Exp 2026-07 | Stride Organics Private LimitedTelangana | The sample does not comply with respect to Dissolution Test as per IPDissolution | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Norfloxacin Tablets I.P. 400mg (Norfloxacin 400) | R-240327Mfg 2024-03 · Exp 2026-02 | Remax Pharmaceuticals | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Nifedipine Sustained Release Tablets IP 10 mg | NF24007Mfg 2024-08 · Exp 2026-01 | Eurokem Laboratories Pvt ltd | Sample does not conform to IP specification for Nifedipine Sustained Release Tablets with respect to the content of NifedipineOther | Drugs Testing Laboratory, Madurai-19State lab |
| Neo-Chloranton | T-3750Mfg 2023-12 · Exp 2025-11 | New Gayzel Pharmaceuticals 6/4 Modern Industrial Estate Bahadurgarh - 124507 Mrk. By : Remedies Pharmaceuticals (India) Pvt Ltd 107A &B Aradhana Bhawan Azadpur Commercial ComplexDelhi | The sample fails in the test for Description & Disintegration test of tabletsDescription | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Nandrolone Blend Injection 350mg/ml (DEXADUR) | TST2301Mfg ? · Exp 2027-04 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Moxi-KT EYE DROPS (Moxifloxacin 0.5 % + Ketorolac 0.4% + H.P.M.C. 0.025 % Opthalmic solution) | 3780Mfg 2024-08 · Exp 2026-07 | Eden Drugs Pvt. Ltd. S.G.R.D.J. Airport Road Meerankot Distt. AmritsarPunjab | Assay of Ketorolac(80.75%)Assay | DTL Baddi Distt Solan HPState lab |
| Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP (BLUCAST-L) | ZP24T176Mfg 2024-08 · Exp 2026-07 | Zantic Pharmaceuticals Pvt. Ltd. (AGMP Certified Unit) G-86Uttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Dissolution of Montelukast & Levocetirizine HydrochlorideDissolution | DTL BaddiState lab |
| Misoprostol Tablets IP 200 mcg(Misotop 200) | SPT241229Mfg 2024-06 · Exp 2026-05 | Salus Pharmaceuticals 480/211Himachal Pradesh | The content of Misoprostol in the sample is less (i.e 13.82% of the lablled amount) than the IP limitsOther | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Metronidazole Tablets IP 400 mg | B240578Mfg 2024-05 · Exp 2027-04 | Bochem Healthcare Pvt. Limited | DissolutionDissolution | RDTL, ChandigarhCDSCO lab |
| Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Folic Acid, Inositol & Niacinamide Softgel Capsules (S-Neuro Plus) | SD240762Mfg 2024-04 · Exp 2025-09 | Bajaj NutraceuticalsUttarakhand | (1) For the received sample Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Folic Acid, Inositol & Niacinamide Softgel Capsules (S-NEURO PLUS), Leakage of the soft gelatin capsules was observed which should not be present as per rule 124B of the Drugs Rules,1945 (2) Does not comply with respect to test for DesintegrationOther | State lab , PuducherryState lab |
| Mefenamic Acid and Paracetamol Suspension (Sarmef-PDS) | SBL-1021Mfg 2024-10 · Exp 2026-09 | Sarthak Biotech Pvt. Ltd | VolumeOther | State Drugs Laboratory, PunjabState lab |
| Maxirest ?LP Tablets | MPT23365Mfg 2024-03 · Exp 2026-02 | Micro Organics Pharmaceuticals (India)Pvt LtdChandigarh | The sample fails in the test for Description of tabletsDescription | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Manoril-BR Syrup (Terbutaline Sulphate, Bromhexine HCL, Guaiphenesin and Menthol Syrup) | ASL24199Mfg 2024-10 · Exp 2026-09 | AASSK Pharmaceuticals Pvt. LtdTamil Nadu | Sample does not conform to Label claim with respect to the content of Bromhexine HydrochlorideLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| MULTIPLE ELECTROLYTES AND DEXTROSE INJ. TYPE-1 I.P. (AROLYTE P) | 1227421SMfg 2024-12 · Exp 2027-11 | Shree KrishnaKeshav Laboratories LtdGujarat | Assay of PotassiumAssay | CDTL-MumbaiCDSCO lab |
| MITO Q7 Syrup (Co Enzyme Q10, L- Carnitine, Benfotiamine, Riboflavin, Pyridoxine HCL | CHS-40170Mfg 2024-09 · Exp 2026-02 | Bion Therapeutics India Pvt.LtdUttarakhand | Assay for Benfotiamine, Riboflavinand,AscorbicAcidAssay | KarnatakaState lab |
| METRONIDAZOLE TABLETS IP (Martigyl-400) | MT-24D03Mfg 2024-04 · Exp 2026-03 | Martin & Brown Bio-sciencesHimachal Pradesh | DissolutionDissolution | RDTL, GuwahatiCDSCO lab |
| Lomojack | CN2305Mfg 2023-04 · Exp 2025-09 | Century Drugs Pvt Ltd. Plot no. 38Madhya Pradesh | The sample does not comply with I.P requirement for Dissolution Test"Dissolution | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| KAAMRAJ (Suspected to contain Sildenafil and Tadalafil (Brahmanands) | BAC0003Mfg 2023-01 · Exp 2025-12 | Brahmanand Ayurveda (OPC) Pvt. LtdPunjab | 1) Identification Test for Sildenafil found to be Negative. 2) Identification test for Tadalafil found to be PositiveIdentification | State Drugs Laboratory, PunjabState lab |
| Itraconazole Ofloxacin, Ornidazole & Clobetasol Propionate Cream (Fondastop C Cream) | 0-102Mfg 2023-09 · Exp 2025-08 | Spen Formulations Pvt Ltd. Plot No. 123 | The sample does not give High Performance Liquid Chromatographic and Thin Layer Chromatographic identification Test for the presence of itraconazole and Clobetasol Propionate.Identification | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Itraconazole Capsules BP 100 mg (ITR 100 | 5007Mfg 2023-07 · Exp 2025-06 | Orley Laboratories Pvt. Ltd. 1817Gujarat | The sample does not comply with B.P requirements for Dissolution TestDissolution | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Isoxsuprine Hydrochloride (SR)Tablets(Siox-Sr) | GT400966AMfg 2024-10 · Exp 2026-09 | Gnosis Pharmaceuticals Pvt.Ltd.Nahan RoadHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Isoxsuprine HydrochlorideAssay | DTL,Jaipur(State Lab)State lab |
| Iron Sucrose Injection USP l00mg (Irogain) | IISI406Mfg 2024-09 · Exp 2026-07 | U/s. Regain LaboratoriesChhattisgarh | Test for Fineness residue onlyOther | KarnatakaState lab |
| Injection Oxytocin Vet. 50 ml Vial | Not applicableMfg ? · Exp ? | Not applicable | pH and SterilitySterility | RDTL, ChandigarhCDSCO lab |
| Injection Oxytocin Vet. 100 ml Vial | Not applicableMfg ? · Exp ? | Not applicable | pH and SterilitySterility | RDTL, ChandigarhCDSCO lab |
| Ibuprofen Oral Suspension BP 100 mg/5ml | IBS-022Mfg 2024-07 · Exp 2026-06 | Medipol Pharmaceuticals India Pvt. Ltd. 1199/3Himachal Pradesh | The sample does not conform to claim as per BP 2024 in respect to the Assay of IbuprofenAssay | DTL Baddi Distt. SolanState lab |
| Halar Cream | HA-292Mfg 2023-07 · Exp 2026-06 | Maxheal Pharmaceuticals (I) Ltd. J-7 M.I.D.C Tarapur Industrial AreaMaharashtra | The content of Neomycin Sulphate (i.e. 18.80% of the labelled amount)Labelling | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Haematinic Capsules (R.B. TONE) | D40652Mfg 2024-11 · Exp 2026-10 | Medley Pharmaceuticals LtdDaman & Diu | Microbial limit test (Total combined yeasts/molds count)Microbial limits | CDTL-MumbaiCDSCO lab |
| Gutwell Suspension, Bacillus clausii 2 billion spores/5ml | PSB-B00225Mfg 2025-01 · Exp 2027-12 | Prosafe Biologicals LLP Survey No:237/EE/1Telangana | Total viable count found Less than 2 billion spores/5mlOther | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Golden Drive 250gm | GDM002NMfg 2023-10 · Exp 2026-09 | Advanced Pakiza Unani LLPMaharashtra | 1. The sample gives identification for the presence of Sildenafil Citrate 2. Found Content of Sildenafil in the sample is 8.49mg/10gmIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| GlimepirideTablets IP 2mg (Glimiz-2), | T24039Mfg 2024-04 · Exp 2026-03 | Knm Pharma Pvt. Ltd.13Gujarat | Assay and IP standards with respect Test for DissolutionAssay | KarnatakaState lab |
| Glimepiride Tablets IP 1mg | PGG24-012Mfg 2024-08 · Exp 2026-07 | Pondchy PharmaceuticalsPuducherry | Sample does not conform to IP specification for Glimepiride Tablets with respect to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Glibenclamide Tablets IP 5mg | NHD24411AMfg 2024-07 · Exp 2025-07 | Nest Healthcare Private limitedGujarat | Sample does not conform to IP specificaion for Glibenclamide Tablets with respec to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Gentamicin Injection IP-2ML | 24BUH85Mfg 2024-08 · Exp 2026-07 | SVP Life SciencesUttarakhand | Sample does not conform to the requirement for pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Gentamicin Injection I.P-2ml | HLI624FMfg 2024-06 · Exp 2025-05 | Himalaya Meditek Pvt LtdUttarakhand | Sample does not conform to the requirement for pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Gabapentin Capsules IP 300mg. (GABATEC-300) | SG2412559Mfg 2024-12 · Exp 2026-11 | Scout Lifescience Pvt. LtdHaryana | Uniformity of WeightUniformity of weight/content | State Drugs Laboratory, PunjabState lab |
| Gabapentin & Nortriptyline Hydrochloride Tablets (GABVONT400) | HT24642Mfg 2024-12 · Exp 2026-11 | HBC Healthcare Pvt.LtdGujarat | The sample does not confirm to the claim with respect to Assay of NortriptylineAssay | DTL,Jaipur (State Lab)State lab |
| Fluconazole IP Powder | FLZ23-2411Mfg 2023-11 · Exp 2028-10 | Mestra Pharma Pvt. LtdUttarakhand | Loss on drying: Does not comply with IPLoss on drying | State Food & Drug Testing Laboratory UttarakhandState lab |
| Fluconazole 150mg Tablets IP (PRATIFLU 150 Tablets | PPTS-2801Mfg 2024-08 · Exp 2027-07 | Pratima PharmaceuticalsMaharashtra | The content of Fluconazole in the sample is less (i.e 31.96% of the stated amount) (I.P. Limits:- Not less than 90% and not more than 110% of the stated Amount)Other | V.P. Khedkar, Pune-Zone 2State lab |
| Fexofenadine Tablets IP (Fexodil 180 mg) | T-4029Mfg 2025-01 · Exp 2026-12 | Jackson Laboratories Pvt. LtdPunjab | Dissolution test after 10 min and after 30 minDissolution | CDL, KolkataCDSCO lab |
| Ferrous Sulphate & Folic Acid Syrup IP | FSF-158Mfg 2024-10 · Exp 2026-09 | Medipol Pharmaceuticals India Pvt. Ltd. 1199/3Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the Test of Free Ferric Compounds & Assay of Folic AcidAssay | DTL Baddi Distt. SolanState lab |
| Fenacin (Diclofenac Diethylammonium + Methyl Salicylate + Menthol Gel) | DG2402Mfg 2024-04 · Exp 2026-03 | Johnson & Smith CoKarnataka | Sample does not conform to Label claim with respect to the content of Methyl SalicylateLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| Enzox Liquid Digestive Supplement | ES-24011/11Mfg 2024-12 · Exp 2026-05 | Tidal Laboratories Pvt. Ltd. Patch-5 | Assay/Content of Pepsin activity.Assay | CDL, KolkataCDSCO lab |
| Entcof Syrup (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate Syrup) | MMR-344Mfg 2024-03 · Exp 2026-02 | Mediguard Remedies | Sample does not conform to Label claim with respect to the content of Terbutalline SulphateLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| Doxycycline and Lactic Acid BacillusTablets(DOXYGLO-LB) | ATG4G566Mfg 2024-07 · Exp 2026-06 | Anrose PharmaHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Doxycycline Hydrochloride IPAssay | DTL,Jaipur (State Lab)State lab |
| Dolomol 650 | RBT-2042Mfg 2024-10 · Exp 2027-06 | Rockbrook Overseas Pvt Ltd | The sample fails in the dissolution test of paracetamolDissolution | Modern Drug Testing Laboratory Kathua (J&K)State lab |
| Dobutamine Hydrochloride Injection IP 5 ml | DBA12404Mfg 2024-08 · Exp 2026-07 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | Particulate matter and DescriptionDescription | CDL, KolkataCDSCO lab |
| Disposable Syringes (5ml) (SUI) | 4051124S11Mfg 2024-11 · Exp 2027-10 | Hindustan Ultra Care LimitedRajasthan | SterillityOther | RDTL, GuwahatiCDSCO lab |
| Dicyclomine Hydrochloride Tablets IP 10 mg | TK24-08Mfg 2024-11 · Exp 2026-10 | Om Biomedic Pvt. LtdUttarakhand | DescriptionDescription | RDTL, GuwahatiCDSCO lab |
| Dicyclomine HCL Powder | DEH/24011RMfg 2025-07 · Exp 2029-06 | Palam Pharma Pvt. LtdGujarat | IdentificationTest- Found to be Negative. Assay of Paracetamol IP-NilAssay | State Food & Drug Testing Laboratory UttarakhandState lab |
| Diclofenac Sodium and Paracetamol Tablets?. (DICLOZEG-P) | TSF-B5792Mfg 2023-10 · Exp 2025-09 | Spen Formulations Pvt. Ltd | The Product is official in I.P 2022 but the same is not mentioned anywhere on the label.Labelling | State Drugs Laboratory, PunjabState lab |
| Diclofenac Sodium Tablets I.P.(Dicloax Plus) | CDTP-265Mfg 2024-09 · Exp 2026-08 | Candor Biotech LtdPunjab | The sample does not conform to the IP with respect Assay of Diclofenac Sodium (NIL) and Found Aceclofenac (57.41 mg/Tab)Assay | DTL,Jaipur (State Lab)State lab |
| Dexamethasone Sodium Phosphate Injection IP (Dexona) | N400726Mfg 2024-06 · Exp 2025-11 | Zydus Healthcare LimitedGujarat | Particulate matter, Assay of Dexamethasone Phosphate and DescriptionAssay | CDL, KolkataCDSCO lab |
| Depcof cough syrup | L-2306077Mfg 2023-06 · Exp 2025-05 | Gopal life sciencesHimachal Pradesh | Assay of Phenylephrine Hydrochloride.Assay | DTL Baddi Distt Solan HPState lab |
| Dapagliflozin Tablets IP (DAPAWOHN) | HT2406181Mfg 2024-06 · Exp 2026-05 | Helax Healthcare Private Limited Khasra No.410 Village Karondi Roorkee Distt HaridwarUttarakhand | Assay and Uniformity of Content of DapagliflozinAssay | DTL Baddi Distt Solan HPState lab |
| Dapagliflozin Tablets IP (DAPAWOHN) | HT2406181Mfg 2024-06 · Exp 2026-05 | Helax Healthcare Private Limited Khasra No.410 Village Karondi Roorkee Distt HaridwarUttarakhand | Assay and Uniformity of Content of DapagliflozinAssay | DTL Baddi Distt Solan HPState lab |
| Compound Sodium Lactate Injection IP (Ringer-Lactate Solution for Injection) | KI124110Mfg 2024-12 · Exp 2027-11 | Ultra Laboratories Pvt. LtdKarnataka | Test for SterilitySterility | KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer Lactate Solution for injectionI.P) RL | 1247988Mfg 2024-11 · Exp 2027-10 | Otsuka Pharmaceuticals India PvtGujarat | Test for SterilitySterility | KarnatakaState lab |
| Compound Sodium Lactate Injection I.P (Ringer's Lactate Solution Injection I.P)RL | 13-4536Mfg 2024-11 · Exp 2027-10 | Ltd | Test for SterilitySterility | KarnatakaState lab |
| Codeine Phosphate, Chlorpheniramine Maleate and Sodium Citrate Cough Linctus (WYKAREX-CD Cough Linctus) | AL-5770Mfg 2023-11 · Exp 2025-10 | Acron PharmaceuticalsGujarat | The Content of Codeine Phosphate in the sample less (i.e 32.50% of the labelled amount)Labelling | B.D. Marewad, FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Clopidogrel and Aspirin Tablets IP (AclizacAS 75) | 2411039Mfg 2024-11 · Exp 2026-10 | Sanctus Global Formulations Limited | The sample does not conform to the IP with respect to Assay of Aspirin & Free Salicylic AcidAssay | DTL,Jaipur (StateState lab |
| Clopidogrel & Aspirin Tablets (75 mg/ 75 mg) | GT241288Mfg 2024-07 · Exp 2026-06 | Theon Pharmaceuticals LtdHimachal Pradesh | DescriptionDescription | CDTL-MumbaiCDSCO lab |
| Ciprofloxacin Injection IP (0.2%w/v) (Ciprox) | 2250946Mfg 2025-02 · Exp 2028-01 | Otsuka Pharmaceutical India Private LimitedGujarat | Particulate contamination.Particulate matter | CDL, KolkataCDSCO lab |
| Ciprofloxacin Hydrochloride Tablets IP 500mg (Cipro-500 Tablets | COP24001Mfg 2024-03 · Exp 2026-02 | Danish Healthcare(P) Ltd. 76/27-28 | The sample does not comply with I.P requirement for DissolutionDissolution | N.S. Bhalerao, Nanded, FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Cefixime and Lactic Acid Bacillus Dispersible Tablets (Micoceff-LB 200 Tablets) | CFL2411001Mfg 2024-11 · Exp 2026-10 | Maxcel Life CareMaharashtra | Identification and Assay of Cefixime Trihydate and Lactic Acid BacillusAssay | RDTL, ChandigarhCDSCO lab |
| Cefixime Tablets IP 200 mg | B240875Mfg 2024-06 · Exp 2026-05 | Bochem Healthcare Pvt. Ltd. 83 | Test of WaterWater content | CDL, KolkataCDSCO lab |
| Cefixime 100 mg/5ml Powder for oral Suspension (Sunderin) | MSSB24005Mfg 2024-11 · Exp 2026-11 | Nector Lifesciences Limited Unit-VIHimachal Pradesh | The sample does not conforms to Patent & Proprietary in repect to the Assay of Anhydrous Cefixime.Assay | DTL Baddi Distt Solan HPState lab |
| Cefixime &Ofloxacin Tablets (CEFXEN-O) | VT240794Mfg 2024-07 · Exp 2026-06 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the claim with respect to assay of CefiximeAssay | DTL,Jaipur (State Lab)State lab |
| Calcium and Vitamin D3 Tablets IP(Tricum-XT) | 1240247Mfg 2024-02 · Exp 2025-07 | Corona Remedies Pvt Ltd. VillageHimachal Pradesh | The Content of Vitamin D3 in the sample is less (i.e. 34.85% of the labelled amount) than the IP limitsLabelling | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Calcium and Vitamin D3 Tablets (Elprocal) | NBT-230543Mfg 2024-01 · Exp 2025-12 | Soft Touch Pharmaceuticals India LtdHimachal Pradesh | Sample does not conform to IP specification for Calcium and Vitamin D3 Tablets with respect to the identification and content of Vitamin D3Identification | Drugs Testing Laboratory, Madurai-19State lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500) | GTL1317Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500) | GTL1295Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA-500) | GTL1316Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL, KolkataCDSCO lab |
| Buprenorphine Injection I.P. (Talgesic Injection) | BUP324002Mfg 2024-06 · Exp 2026-05 | Indus Pharma Pvt. LtdRajasthan | Spurious Identification and Assay of Buprenorphine Hydrochloride, Particulate matter and DescriptionAssay | CDL, KolkataCDSCO lab |
| Buprenorphin Injection I.P. (Noophin Injection ) | LM18898Mfg 2022-11 · Exp 2028-10 | Cooper Pharma LimitedUttarakhand | Related Substances, Particulate matter, Sterility , Assay of Buprenorphine Hydrochloride eq. to Buprenorphine and DescriptionAssay | CDL, KolkataCDSCO lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP 4 ml | 17B24005Mfg 2024-09 · Exp 2026-08 | Radiant Parenterals LtdGujarat | pH, Bacterial Endotoxins Test, Particulate Matter in Injections and DescriptionDescription | CDL, KolkataCDSCO lab |
| Bromhexine Hcl Tabs. IP 8mg (Bronco) | BRO-2401Mfg 2024-06 · Exp 2027-05 | Medibest Pharma Pvt. Ltd. N-31 | (1) The label of the received sample Bromhexine Hcl Tabs. IP 8mg (BRONCO), mentions the proper name of the drug whose font size is smaller than the brand name whereas the proper name of the drug should be at least two font size larger than the brand name as prescribed under Rule 96 (1), i (A) of the Drugs and Cosmetics Rules. (2) The name of the received sample mentions as Bromhexine HCL Tabs. IP 8mg, however Bromhexine HCL Tabs IP is an official monograph hence should be labelled as Bromhexine HCL Tabs IPLabelling | State lab , PuducherryState lab |
| Boldenone Undecylenate Injection 400mg/ml (VEBOLDEX 400) | TST2301Mfg ? · Exp 2027-04 | Thaiger Pharma | 1) Manufacturing Date is not mentioned on the label. 2) Manufacturing address is not mentioned on the labelLabelling | State Drugs Laboratory, PunjabState lab |
| Betamethasone Valerate Ointment IP 0.1% w/w | B73Mfg 2024-08 · Exp 2026-07 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | Drugs Testing Laboratory, Chennai-06State lab |
| Betamethasone Sodium Phosphate Injection IP (Betagin 1 ml) | P24L107Mfg 2024-08 · Exp 2026-07 | Paksons Pharmaceuticals Private LimitedHaryana | Particulate matter, Assay of Betamethasone Sodium Phosphate and DescriptionAssay | CDL, KolkataCDSCO lab |
| Betahistine Dihydrochloride Tablet I.P (CGHEST-8) | CT24250284AMfg 2024-05 · Exp 2026-04 | CMG Biotech Pvt. Ltd (Unit II) | DescriptionDescription | CDTL- IndoreCDSCO lab |
| Bacillus clausii Bakteriya shtammining polireist Suspension, Bacillus clausii Bakteriya shtammining polirezistent 2mlrd. Tirik bakteriyalar/5ml | PSB-B00125Mfg 2025-01 · Exp 2026-12 | Prosafe Biologicals LLP Survey No:237/EE/1Telangana | Total viable count found Less than 2 billion spores/5mlOther | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Azithromycin Tablets IP 500mg (Ronnin 500 Tablets) | PPTC082Mfg 2023-11 · Exp 2026-10 | Pratima PharmaceuticalsMaharashtra | 1. The sample does gives identification for the presence of Azithromycin 2. Additional identification:-The sample gives identification for the presence of Paracetamol.3. Found Content of Paracetamol in the sample is 147.24mg/TabIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Azithromycin Tablets IP 500 mg | DL-52Mfg 2024-10 · Exp 2026-09 | DUTCH FormulationsHimachal Pradesh | Dissolution, Uniformity of weight and Assay of Azithromycin Dihydrate calculated as AzithromycinAssay | RDTL, ChandigarhCDSCO lab |
| Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) | Not mentionedMfg ? · Exp ? | Paradox PharmaceuticalsHimachal Pradesh | Identification, Dissolution and Assay of Azithromycin Dihydrate Calculated as Anhydrous AzithromycinAssay | RDTL, ChandigarhCDSCO lab |
| Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) | AZR2411010Mfg 2025-01 · Exp 2026-12 | Paradox PharmaceuticalsHimachal Pradesh | Identification, Dissolution and the Assay of AzithromycinAssay | RDTL, ChandigarhCDSCO lab |
| Azithromycin Oral Suspension | A004Mfg 2023-12 · Exp 2025-11 | Smith & Kenner Pharmaceuticals Pvt.LtdTelangana | The label of the drug should be mentioned as Azithromycin Oral suspension IP. But the letters IP is not mentioned on the labelLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Axid 200 (Sucralfate Oral Suspension) | 624-470Mfg 2024-06 · Exp 2026-05 | Zee Laboratories LtdHimachal Pradesh | Sample does not conform with respect to General requirements for liquid dosage formOther | Drugs Testing Laboratory, Chennai-06State lab |
| Atorvastatin Tablets IP 10mg (Atosar-10) | SBT-813Mfg 2024-03 · Exp 2026-02 | Sarthak Biotech Pvt. Ltd | DescriptionDescription | State Drugs Laboratory, PunjabState lab |
| Atorvastatin Tablets IP 10mg | CT240237AMfg 2024-07 · Exp 2025-06 | Candour PharmaceuticalsHimachal Pradesh | Sample does not conform to IP specification for Atorvastatin Tablets with respect to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Amoxycillin& Potassium Clavulanate Tablets I.P. 625 mg (TIMOX ? CV 625) | AXP5F5007Mfg 2025-01 · Exp 2026-12 | Sucantis Bio Tech Pvt. LtdUttarakhand | The sample does not conform to standard quality in respect of the test for Dissolution of AmoxycillinDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin& Potassium Clavulanate Tablets I.P (AMOXMED ? CV 625 Tablets) | ABT24071Mfg 2024-05 · Exp 2025-10 | Alexa PharmaceuticalsHimachal Pradesh | The sample does not conform to standard quality in respect of the test for Dissolution & AssayAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin& Potassium Clavulanate Tablets I.P (AGECLAV ? 375 Tablets) | JMT-240801AMfg 2024-08 · Exp 2026-01 | JMM Formulation Pvt. LtdHimachal Pradesh | The Sample does not conform to Standard Quality in respect of the test for Dissolution of AmoxycillinDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin with Potassium Clavulanate Tablets I.P. (CLAIM ? CV 625) | CT/24/747Mfg 2024-10 · Exp 2026-03 | Ciphem PharmaGujarat | The Sample does not conform to standard in respect of the test for Uniformity of weight, Dissolution & AssayAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amoxycillin and Potassium Clavulanate with Lactic Acid Bacillus Tablets (Polo-625 LB Tablets) | PL2406001Mfg 2024-10 · Exp 2026-11 | Paradox PharmaceuticalsHimachal Pradesh | Identification and Assay of Amoxycillin Trihydrate, Potassium Clavulanate and Lactic Acid BacillusAssay | RDTL, ChandigarhCDSCO lab |
| Amoxycillin and Potassium Clavulanate Tablets IP (Rumentin-625 Tablets) | RUM2411002Mfg 2024-11 · Exp 2026-10 | Rextuse PharmaceuticalsUttarakhand | Identification and Assay of Amoxycillin Trihydrate and Potassium Clavulanate and Dissolution of Amoxycillin Trihydrate and Potassium ClavulanateAssay | RDTL, ChandigarhCDSCO lab |
| Amoxycillin and Potassium Clavulanate Oral Suspension RIGHTCLAV 228.5 Dry Syrup | ACAG24001EMfg 2024-04 · Exp 2025-09 | J.M.LaboratoriesHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with respect to pH and the content of Clavulanic Acid in Potassium Clavulanate dilutedpH | Drugs Testing Laboratory, Madurai-19State lab |
| Amoxycillin Trihydrate Capsules I.P. (Zymox-500 (Yellow)) | ZYMC-2407Mfg 2024-04 · Exp 2026-04 | Laborate Pharmaceuticals India LtdHaryana | Assay/ content of AmoxycillinAssay | CDTL-MumbaiCDSCO lab |
| Amoxycillin Capsules IP 500mg (Moxgo-500) | MOXG-2404001Mfg 2024-07 · Exp 2026-06 | RMIS PharmaceuticalsChhattisgarh | The sample does not conform to the IP as it does not contain Amoxycillin ( NIL)Other | DTL, Jaipur (State Lab)State lab |
| Amoxycillin Capsules IP 250mg (Amoxi 250) | MT14AC08Mfg 2023-08 · Exp 2025-07 | Malik Lifesciences Pvt. LtdUttarakhand | Does not comply with respect to test for AssayAssay | State lab , PuducherryState lab |
| Amoxycillin & Potassium Clavulanate for Oral Suspension, | UPS-245CMfg 2024-01 · Exp 2025-06 | Ultra Drugs Pvt.LtdHimachal Pradesh | The drug product Amoxcycillin and potassium Clavulanate for Oral suspension is official in the current edition of IP 2022. But the designation in conjiction with the product title Amoxycillin and Potassium Clavulanate for Oral suspension IP is not mentioned on the product LabelLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Amlodipine Besylate Tablets I.P. 2.5 mg (AMLODOSE ? 2.5 ) | SPT240321Mfg 2024-02 · Exp 2026-01 | Salus PharmaceuticalsHimachal Pradesh | The Sample does not conform to standard in respect of the test for Assay & Uniformity of ContentAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Amikacin Sulphate Injection IP 500mg (Amikablast 500 Injection) | W373Mfg 2023-07 · Exp 2025-06 | Macin Remedies India Ltd. B-21 | The content of Amikacin in the sample is more (i.e 183.99% of the lablled amount) than the I.P limitsOther | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Ambroxol Hydrochloride, Terbutaline sulphate, Guaiphenesin & Menthol syrup (TEXORIL-AM Syrups), | MXS-9081Mfg 2023-11 · Exp 2025-10 | Maxtra LaboratoriestifindustrialparkTelangana | The drug failed to indicate the common name of the color contained in the drug on the label of the product, as required by Rule 127(2) of the Drugs Rules, 1945. It was mentioned on the label as Approved Colours used.Labelling | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Vitamin B6 &Vitamin D3 Tablets) | AT-052410Mfg 2024-05 · Exp 2026-04 | East African (India) OverseasUttarakhand | Test for Disintegration onlyDisintegration | KarnatakaState lab |
| Alcinac-SR Tablets (Aceclofenac Sustained-release Tablets) | 9244001Mfg 2024-05 · Exp 2026-04 | Leeford Healthcare Ltd. At: Plot No. 79-A & 79-BHimachal Pradesh | Dissolution of AceclofenacDissolution | Drugs Testing Laboratory, BaddiState lab |
| Albendazole tablets IP 400mg | T24/006AMfg 2024-12 · Exp 2026-11 | SamkemMadhya Pradesh | Sample does not meet the Specifications wrt. Dissolution Test as per IPDissolution | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Albendazole tablets IP 400mg | T24/021AMfg 2024-12 · Exp 2026-11 | SamkemMadhya Pradesh | The sample does not comply with respect to Dissolution Test as per IP 2022Dissolution | State Lab, Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablets IP 400 mg (ALBISTI ? 400) | PI28AH05Mfg 2023-07 · Exp 2025-12 | Pure & Cure Healthcare Pvt. LtdUttarakhand | The Sample does not conform to standard in respect of the test for DissolutionDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Albendazole Tablets I.P. 400 mg (B-ZOLE 400 mg) | T50120AMfg 2025-02 · Exp 2027-01 | Samson Laboratories Pvt. LtdHimachal Pradesh | The sample does not conform to standard quality in respect of the test for DissolutionDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab |
| Albendazole Oral Suspension IP (Vet.) | SLG24095Mfg 2024-03 · Exp 2026-02 | Safecon Lifesciences Pvt. Ltd | The sample does not conform to the IP with respect to Assay of AlbendazoleAssay | DTL, Jaipur (State Lab)State lab |
| Albendazole Chewable Tablets IP (Alsia-400 Tab | SPD-618Mfg 2024-10 · Exp 2026-09 | Sia Pharma Pvt Ltd. (Who-Gmp Certified Company) Plot no. 170Haryana | The sample does not comply with I.P requirement for Dissolution TestDissolution | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Advanced Pakiza Unani's Golden Knight Cream | PUNC02Mfg 2024-04 · Exp 2027-03 | Advanced Pakiza Unani LLP | 1. The sample gives identification for the presence of Tadalafil. . 2. Found Content of Tadalafil in the sample is 0.17mg/gmIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Advanced Pakiza Unani's Golden Knight Capsules | GKC002AMfg 2023-11 · Exp 2026-10 | Advanced Pakiza Unani LLP | 1. The sample gives identification for the presence of Sildenafil Citrate and Tadalafil. 2. Found Content of Sildenafil in the sample is 9.65mg/Cap 3. Found Content of Tadalafil in the sample is 12.77mg/CapIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Advanced Pakiza Unani's Golden Knight 125g | PUN45Mfg 2024-11 · Exp 2027-10 | Advanced Pakiza Unani LLPMaharashtra | 1. The sample gives identification for the presence of Sildenafil Citrate. 2. Found Content of Sildenafil in the sample is 33.72 mg/10gmIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Acidom-DSR Capusles | 2560301CMfg 2023-07 · Exp 2025-06 | LifecarePuducherry | The content of Rabeprozole in the sample is less (i.e 31.85% of the lablled amount) than permissible limitsOther | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab |
| Acelofenac & Paracetamol Tablets (ACELOZAL-P) | YLT25005Mfg 2025-01 · Exp 2026-12 | YL Pharma BaddiHimachal Pradesh | The sample does not conforms to Patent & Proprietary in repect to the Assay of Aceclofenac.Assay | DTL Baddi Distt Solan HPState lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets (ACIJAN-SP Tablets) | AF-23T683Mfg 2023-10 · Exp 2025-09 | Affine Formulations Ltd.1947/3Himachal Pradesh | The Content of Serratiopeptidase in the sample is less(i.e 41.54% of lebelled amount)Other | V.P. Mahajan, Jalna. FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab |
| Aceclofenac Tablets I.P 100 mg | T4167Mfg 2024-05 · Exp 2026-04 | Zest PharamaMadhya Pradesh | DescriptionDescription | CDTL- IndoreCDSCO lab |
| Aceclofenac Paracetamol & Serratiopeptidase Tablets. (Aceclofen-SP) | PBT-2024101Mfg 2024-05 · Exp 2026-04 | Presun Biotech | The contents of Serratiopeptidase found to be 8.06mg per tablet (80.6%) against labeled claim of 10.0mg per tablet.Labelling | State Drugs Laboratory, PunjabState lab |
| Aceclofenac & Paracetamol Tablets (Aceclon-P) | NTT250578Mfg 2025-02 · Exp 2028-01 | Nanoceut Therapeutics Pvt. LtdPuducherry | The sample received is labelled as Aceclofenac And Paracetamol Tablets (Aceclon-P) , however Aceclofenac And Paracetamol Tablets is an official IP monograph (IP Addendum 2024) hence should be labelled as Aceclofenac And Paracetamol Tablets IPLabelling | State lab , PuducherryState lab |
| Aceclofenac & Paracetamol Tablets (A-Sid Tablets) | HT-2401253Mfg 2024-12 · Exp 2026-11 | Helax Healthcare Private LimitedUttarakhand | (1)The sample received is labelled as Aceclofenac & Paracetamol Tablets, however Aceclofenac & Paracetamol Tablets is an official IP monograph (Addendum 2024) hence should be labelled as Aceclofenac & Paracetamol Tablets IP. (2)For the received sample, Discolouration was observed. (3) Does not comply with respect to test for Uniformity of weight and Assay for Aceclofenac and ParacetamolAssay | State lab , PuducherryState lab |
| Aceclofenac & Paracetamol Tablets (Elzefen-P ) | PC24021Mfg 2024-03 · Exp 2026-02 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | Assay of AceclofenacAssay | CDL, KolkataCDSCO lab |
| ALBENDAZOLE TABLETS I.P. | PGT24407Mfg 2024-07 · Exp 2027-06 | Affy ParenteralsHimachal Pradesh | Dissolution of AlbendazoleDissolution | RDTL, ChandigarhCDSCO lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (188 rows). Revised CDSCO lists are diffed on each monthly rebuild.